[ET Net News Agency, 24 October 2019] Sinopharm Group Co. Ltd. (01099) announced the
results of its subsidiary China National Medicines Corporation Ltd.
Its net profit attributable to shareholders of the listed company was RMB1.07 billion
for the nine months ended 30 September 2019, a year-on-year increase of 12.71%. The
earnings per share were RMB1.4015.
The operating income was RMB32.71 billion, a year-on-year increase of 13.67%. (RC)